Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

XLVvsVHTETF Comparison

ETF 1
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
+2%
VS
ETF 2
VHT

Vanguard Health Care ETF

This fund is part of
US Health Care
+2%

State Street Health Care Select Sector SPDR ETF (XLV) and Vanguard Health Care ETF (VHT) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: Healthcare and Consumer Non-Cyclicals. XLV is less expensive with a Total Expense Ratio (TER) of 0.08%, versus 0.09% for VHT. XLV is up 6.79% year-to-date (YTD) with +$229M in YTD flows. VHT performs better with 8.01% YTD performance, and -$177M in YTD flows. Run a side-by-side ETF comparison of XLV and VHT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XLV vs VHT performance and flow charts

Performance

02468101214%Jun 2Jun 9Jun 16Jun 24Jul 1

Cumulative Flows

0 M200 M400 M600 M800 MJun 2Jun 9Jun 16Jun 24Jul 1

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/02/2026
1M3MYTD1Y3Y5Y
Perf.
XLV
VHT
+12.50%+13.49%
+12.13%+13.43%
+6.79%+8.01%
+23.19%+25.83%
+30.86%+32.99%
+38.58%+32.43%
Flows
XLV
VHT
+$867M+$105M
-$1.02B+$34M
+$229M-$177M
+$705M-$537M
-$6.61B-$2.37B
+$4.84B-$524M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XLV
VHT
+17.68%+17.16%
+15.62%+15.33%
+14.21%+14.22%
+14.88%+15.33%
Max drawdown
XLV
VHT
-4.56%-4.24%
-10.51%-10.39%
-17.05%-16.88%
-17.05%-17.77%
Max drawdown duration
XLV
VHT
43d32d
116d169d
444d435d
444d767d
Trading data

Create an account to view trading data

Join for free
XLV
VHT
Last sale
7/2/2026 at 1:30 PM
$163.74
$308.41
Previous close
07/02/2026
$159.54
$300.84
Consolidated volume
07/02/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XLV
VHT
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/2/2026 at 1:30 PM
Live
Closed
XLV
VHT
Last price
$163.74
$308.41
1D performance
+2.63%
+2.52%
AuM$42.15 B$18.38 B
E/R0.08%0.09%
Characteristics
XLV
VHT
Management strategyPassivePassive
ProviderState Street Investment ManagementVanguard
BenchmarkS&P Health Care Select Sector IndexMSCI US IMI Health Care 25/50 Index
N° of holdings59422
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateDecember 16, 1998January 26, 2004
ESGNoNo
Advertisement
Exposure

Countries

XLV
USA
97.58%
Other
2.42%
VHT
USA
97.01%
Other
2.99%

Sectors

XLV
Healthcare
97.58%
Other
2.42%
VHT
Healthcare
97.65%
Other
2.35%
Advertisement

Diversification

XLV

Total weight of top 15 holdings out of 15

71.84%
VHT

Total weight of top 15 holdings out of 15

61.3%

Top 15 holdings

Data as of May 31, 2026
XLV
Eli Lilly & Co.
16.19%
Johnson & Johnson
10.04%
AbbVie, Inc.
7.12%
UnitedHealth Group, Inc.
6.37%
Merck & Co., Inc.
5.45%
Thermo Fisher Scientific, Inc.
3.42%
Amgen, Inc.
3.35%
Gilead Sciences, Inc.
3.08%
Intuitive Surgical, Inc.
2.79%
Pfizer Inc.
2.75%
Abbott Laboratories
2.75%
Bristol Myers Squibb Co.
2.15%
CVS Health Corp.
2.14%
Danaher Corp.
2.13%
Vertex Pharmaceuticals, Inc.
2.10%
VHT
Eli Lilly & Co.
13.99%
Johnson & Johnson
8.44%
AbbVie, Inc.
6.07%
UnitedHealth Group, Inc.
5.44%
Merck & Co., Inc.
4.63%
Thermo Fisher Scientific, Inc.
2.88%
Amgen, Inc.
2.86%
Gilead Sciences, Inc.
2.63%
Intuitive Surgical, Inc.
2.38%
Abbott Laboratories
2.35%
Pfizer Inc.
2.35%
Bristol Myers Squibb Co.
1.84%
Danaher Corp.
1.83%
CVS Health Corp.
1.82%
Vertex Pharmaceuticals, Inc.
1.79%
Frequently asked questions about XLV and VHT

How have the XLV and VHT ETFs performed in 2026?

As of July 2, 2026, XLV is up 6.79% year-to-date (YTD), while VHT has returned 8.01%. That puts VHT better performer ahead so far this year.

Which ETF is attracting more investor money: XLV or VHT?

Year-to-date, the XLV ETF saw +$229M in flows, compared to -$177M for VHT.

Which ETF is more volatile: XLV or VHT?

Over the past year, XLV had a volatility of 15.62%, while VHT experienced 15.33%.

Which ETF is bigger: XLV or VHT?

As of July 2, 2026, XLV holds $42.15 B in assets under management (AUM), while VHT manages $18.38 B.

What sectors do the XLV and VHT ETFs invest in?

XLV leans toward sectors like Healthcare. Meanwhile, VHT focuses on Healthcare.

What are the top holdings of the XLV ETF and VHT ETF?

XLV top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. VHT holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: XLV or VHT?

XLV holds 59 securities with 71.84% of its assets in the top 15. VHT has 422 securities and a top 15 weight of 61.3%.

Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026